EU5 Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: September 04, 2025 Report Code: GDME20518CRDB-ST

Select Item

GlobalData’s “EU5 Contrast Agents Market Outlook to 2033” is a comprehensive databook report, covering key market data on the EU5 Contrast Agents market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Computed Tomography (CT) Contrast Agents, Magnetic Resonance Imaging (MRI) Contrast Agents and Ultrasound Contrast Agents (Microbubbles)

The EU5 Contrast Agents Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Contrast Agents Market.
• Global corporate-level profiles of key companies operating within the EU5 Contrast Agents Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Contrast Agents is segmented as follows – _x000D_

• Computed Tomography (CT) Contrast Agents_x000D_

• Magnetic Resonance Imaging (MRI) Contrast Agents_x000D_

• Ultrasound Contrast Agents (Microbubbles)

Reasons to Buy

The EU5 Contrast Agents Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Bayer AG_x000D_
Bracco Imaging SpA_x000D_
GE HealthCare Technologies Inc_x000D_
Guerbet SA_x000D_
Lantheus Medical Imaging Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Contrast Agents Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Contrast Agents Market, EU5 10

3.1 Contrast Agents Market, EU5, Revenue ($m), 2018-2033 10

3.2 Contrast Agents Market, EU5, Revenue ($m), 2018-2033 12

3.3 Contrast Agents Market, EU5, Volume (Units), 2018-2033 15

3.4 Contrast Agents Market, EU5, Volume (Units), 2018-2033 17

3.5 Contrast Agents Market, EU5, Company Share by Revenue ($m), 2024 20

4 Contrast Agents Market, United Kingdom 22

4.1 Contrast Agents Market, United Kingdom, Revenue ($m), 2018-2033 22

4.1.1 Computed Tomography (CT) Contrast Agents Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 24

4.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 26

4.2 Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 28

4.2.1 Computed Tomography (CT) Contrast Agents Market, United Kingdom, Volume (Units), by Segment, 2018-2033 30

4.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Volume (Units), by Segment, 2018-2033 33

4.3 Contrast Agents Market, United Kingdom, Average Price ($) , 2018-2033 35

4.4 Contrast Agents Market, United Kingdom, Company Share by Revenue ($m), 2024 36

5 Contrast Agents Market, France 38

5.1 Contrast Agents Market, France, Revenue ($m), 2018-2033 38

5.1.1 Computed Tomography (CT) Contrast Agents Market, France, Revenue ($m), by Segment, 2018-2033 40

5.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Revenue ($m), by Segment, 2018-2033 42

5.2 Contrast Agents Market, France, Volume (Units), 2018-2033 44

5.2.1 Computed Tomography (CT) Contrast Agents Market, France, Volume (Units), by Segment, 2018-2033 47

5.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Volume (Units), by Segment, 2018-2033 50

5.3 Contrast Agents Market, France, Average Price ($) , 2018-2033 52

5.4 Contrast Agents Market, France, Company Share by Revenue ($m), 2024 53

6 Contrast Agents Market, Italy 55

6.1 Contrast Agents Market, Italy, Revenue ($m), 2018-2033 55

6.1.1 Computed Tomography (CT) Contrast Agents Market, Italy, Revenue ($m), by Segment, 2018-2033 57

6.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Revenue ($m), by Segment, 2018-2033 59

6.2 Contrast Agents Market, Italy, Volume (Units), 2018-2033 61

6.2.1 Computed Tomography (CT) Contrast Agents Market, Italy, Volume (Units), by Segment, 2018-2033 63

6.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Volume (Units), by Segment, 2018-2033 66

6.3 Contrast Agents Market, Italy, Average Price ($) , 2018-2033 68

6.4 Contrast Agents Market, Italy, Company Share by Revenue ($m), 2024 69

7 Contrast Agents Market, Spain 71

7.1 Contrast Agents Market, Spain, Revenue ($m), 2018-2033 71

7.1.1 Computed Tomography (CT) Contrast Agents Market, Spain, Revenue ($m), by Segment, 2018-2033 73

7.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Revenue ($m), by Segment, 2018-2033 75

7.2 Contrast Agents Market, Spain, Volume (Units), 2018-2033 77

7.2.1 Computed Tomography (CT) Contrast Agents Market, Spain, Volume (Units), by Segment, 2018-2033 79

7.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Volume (Units), by Segment, 2018-2033 82

7.3 Contrast Agents Market, Spain, Average Price ($) , 2018-2033 84

7.4 Contrast Agents Market, Spain, Company Share by Revenue ($m), 2024 85

8 Contrast Agents Market, Germany 87

8.1 Contrast Agents Market, Germany, Revenue ($m), 2018-2033 87

8.1.1 Computed Tomography (CT) Contrast Agents Market, Germany, Revenue ($m), by Segment, 2018-2033 89

8.1.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Revenue ($m), by Segment, 2018-2033 91

8.2 Contrast Agents Market, Germany, Volume (Units), 2018-2033 93

8.2.1 Computed Tomography (CT) Contrast Agents Market, Germany, Volume (Units), by Segment, 2018-2033 96

8.2.2 Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Volume (Units), by Segment, 2018-2033 99

8.3 Contrast Agents Market, Germany, Average Price ($) , 2018-2033 101

8.4 Contrast Agents Market, Germany, Company Share by Revenue ($m), 2024 102

9 Overview of Key Companies in EU5 Contrast Agents Market 104

9.1 Bayer AG 104

9.1.1 Company Overview 104

9.2 Bracco Imaging SpA 104

9.2.1 Company Overview 104

9.3 GE HealthCare Technologies Inc 104

9.3.1 Company Overview 104

9.4 Guerbet SA 104

9.4.1 Company Overview 104

9.5 Lantheus Medical Imaging Inc 105

9.5.1 Company Overview 105

10 Contrast Agents Market Pipeline Products 106

11 Appendix 111

11.1 Research Methodology 112

11.1.1 Coverage 112

11.1.2 Secondary Research 112

11.1.3 Primary Research 113

11.1.4 Market Modeling and Forecasting 114

11.1.5 Company Share Analysis 115

11.1.6 Benchmarking 115

11.2 GlobalData Consulting 116

11.3 Contact Us 116

11.4 Disclaimer 116

Table

Table 1: Contrast Agents Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Contrast Agents Market, EU5, Revenue ($m), USD Constant, 2018-2033 14

Table 3: Contrast Agents Market, EU5, Volume (Units), 2018-2033 16

Table 4: Contrast Agents Market, EU5, Volume (Units), 2018-2033 19

Table 5: Contrast Agents Market, EU5, Company Share by Revenue ($m), 2024 21

Table 6: Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 23

Table 7: Computed Tomography (CT) Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 25

Table 8: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 27

Table 9: Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 29

Table 10: Computed Tomography (CT) Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 31

Table 11: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 34

Table 12: Contrast Agents Market, United Kingdom, Average Price ($), 2018-2033 35

Table 13: Contrast Agents Market, United Kingdom, Company Share by Revenue ($m), 2024 37

Table 14: Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 39

Table 15: Computed Tomography (CT) Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 41

Table 16: Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 43

Table 17: Contrast Agents Market, France, Volume (Units), 2018-2033 45

Table 18: Computed Tomography (CT) Contrast Agents Market, France, Volume (Units), 2018-2033 48

Table 19: Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Volume (Units), 2018-2033 51

Table 20: Contrast Agents Market, France, Average Price ($), 2018-2033 52

Table 21: Contrast Agents Market, France, Company Share by Revenue ($m), 2024 54

Table 22: Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 56

Table 23: Computed Tomography (CT) Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 58

Table 24: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 60

Table 25: Contrast Agents Market, Italy, Volume (Units), 2018-2033 62

Table 26: Computed Tomography (CT) Contrast Agents Market, Italy, Volume (Units), 2018-2033 64

Table 27: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Volume (Units), 2018-2033 67

Table 28: Contrast Agents Market, Italy, Average Price ($), 2018-2033 68

Table 29: Contrast Agents Market, Italy, Company Share by Revenue ($m), 2024 70

Table 30: Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 72

Table 31: Computed Tomography (CT) Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 74

Table 32: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 76

Table 33: Contrast Agents Market, Spain, Volume (Units), 2018-2033 78

Table 34: Computed Tomography (CT) Contrast Agents Market, Spain, Volume (Units), 2018-2033 80

Table 35: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Volume (Units), 2018-2033 83

Table 36: Contrast Agents Market, Spain, Average Price ($), 2018-2033 84

Table 37: Contrast Agents Market, Spain, Company Share by Revenue ($m), 2024 86

Table 38: Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 88

Table 39: Computed Tomography (CT) Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 90

Table 40: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 92

Table 41: Contrast Agents Market, Germany, Volume (Units), 2018-2033 94

Table 42: Computed Tomography (CT) Contrast Agents Market, Germany, Volume (Units), 2018-2033 97

Table 43: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Volume (Units), 2018-2033 100

Table 44: Contrast Agents Market, Germany, Average Price ($), 2018-2033 101

Table 45: Contrast Agents Market, Germany, Company Share by Revenue ($m), 2024 103

Table 46: Contrast Agents Market Pipeline Products 106

Table 47: Total Number of Primary Research Participants, Diagnostic Imaging Market, by Country 113

Figures

Figure 1: Contrast Agents Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033 10

Figure 2: Contrast Agents Market, EU5, Revenue ($m), USD Constant, 2018-2033 12

Figure 3: Contrast Agents Market, EU5, Volume (Units), 2018-2033 15

Figure 4: Contrast Agents Market, EU5, Volume (Units), 2018-2033 17

Figure 5: Contrast Agents Market, EU5, Company Share (%), 2024 20

Figure 6: Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 22

Figure 7: Computed Tomography (CT) Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 24

Figure 8: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 26

Figure 9: Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 28

Figure 10: Computed Tomography (CT) Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 30

Figure 11: Magnetic Resonance Imaging (MRI) Contrast Agents Market, United Kingdom, Volume (Units), 2018-2033 33

Figure 12: Contrast Agents Market, United Kingdom, Company Share (%), 2024 36

Figure 13: Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 38

Figure 14: Computed Tomography (CT) Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 40

Figure 15: Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Revenue ($m), USD Constant, 2018-2033 42

Figure 16: Contrast Agents Market, France, Volume (Units), 2018-2033 44

Figure 17: Computed Tomography (CT) Contrast Agents Market, France, Volume (Units), 2018-2033 47

Figure 18: Magnetic Resonance Imaging (MRI) Contrast Agents Market, France, Volume (Units), 2018-2033 50

Figure 19: Contrast Agents Market, France, Company Share (%), 2024 53

Figure 20: Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 55

Figure 21: Computed Tomography (CT) Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 57

Figure 22: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Revenue ($m), USD Constant, 2018-2033 59

Figure 23: Contrast Agents Market, Italy, Volume (Units), 2018-2033 61

Figure 24: Computed Tomography (CT) Contrast Agents Market, Italy, Volume (Units), 2018-2033 63

Figure 25: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Italy, Volume (Units), 2018-2033 66

Figure 26: Contrast Agents Market, Italy, Company Share (%), 2024 69

Figure 27: Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 71

Figure 28: Computed Tomography (CT) Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 73

Figure 29: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Revenue ($m), USD Constant, 2018-2033 75

Figure 30: Contrast Agents Market, Spain, Volume (Units), 2018-2033 77

Figure 31: Computed Tomography (CT) Contrast Agents Market, Spain, Volume (Units), 2018-2033 79

Figure 32: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Spain, Volume (Units), 2018-2033 82

Figure 33: Contrast Agents Market, Spain, Company Share (%), 2024 85

Figure 34: Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 87

Figure 35: Computed Tomography (CT) Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 89

Figure 36: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Revenue ($m), USD Constant, 2018-2033 91

Figure 37: Contrast Agents Market, Germany, Volume (Units), 2018-2033 93

Figure 38: Computed Tomography (CT) Contrast Agents Market, Germany, Volume (Units), 2018-2033 96

Figure 39: Magnetic Resonance Imaging (MRI) Contrast Agents Market, Germany, Volume (Units), 2018-2033 99

Figure 40: Contrast Agents Market, Germany, Company Share (%), 2024 102

EU5 Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diagnostic Imaging reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at EU5 Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others in real time.

  • Access a live EU5 Contrast Agents Market Outlook to 2033: Computed Tomography (CT) Contrast Agents, Ultrasound Contrast Agents (Microbubbles) and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more